Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-01-15 @ 5:02 PM
Study NCT ID:
NCT01779518
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2014-01-16
First Post:
2013-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Sponsor:
Gilead Sciences
Organization: